|
Study
|
Mortality outcome
|
AUC (95% CI)
|
Cutoff (%)
|
Sn
|
Sp
|
PPV
|
NPV
|
LR+
|
LR−
|
|---|
|
Dwivedi [31]
|
ICU
|
0.57 (0.43–0.70)
|
66
|
–
|
–
|
0.66
|
0.64
|
–
|
–
|
|
Karamarkovic [38]
|
Mortality
|
0.92
|
66
|
0.8
|
0.875
|
0.67
|
0.94
|
6.4
|
0.23
|
|
Koyama [36]
|
28-day
|
0.64 (0.45–0.79)
|
37
|
0.53
|
0.75
|
0.35
|
0.87
|
2.12
|
0.63
|
|
Liaw [33]
|
28-day
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
|
Mihajlovic [30]
|
28-day
|
0.65
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
|
Lorente [34]
|
28-day
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
|
Umemura [32]
|
28-day
|
0. 85 (0.74–0.96)
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
|
Walborn [35]
|
28-day
|
0.71
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
- AUC area under curve, Sn sensitivity, Sp specificity, PPV positive predictive value, NPV negative predictive value, LR+ positive likelihood ratio, LR− negative likelihood ratio
